智通财经APP获悉，1月26日，港股医疗检测赛道迎来重磅资本动作。国际著名投资机构GIC Private Limited增持艾迪康控股(09860)89.15万股，每股作价5港元，总金额445.75万港元。增持后最新持股数目为3683.75万股，持股比例达5.07%，正式触发举牌线。值得注意的是，近期艾迪康在AI医疗检测领域的战略布局获得了市场的广泛关注。站在AI技术加速重构医疗体系的节点之上，...
Source Link智通财经APP获悉，1月26日，港股医疗检测赛道迎来重磅资本动作。国际著名投资机构GIC Private Limited增持艾迪康控股(09860)89.15万股，每股作价5港元，总金额445.75万港元。增持后最新持股数目为3683.75万股，持股比例达5.07%，正式触发举牌线。值得注意的是，近期艾迪康在AI医疗检测领域的战略布局获得了市场的广泛关注。站在AI技术加速重构医疗体系的节点之上，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.